Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab).
Ribera JM, García O, Grande C, Esteve J, Oriol A, Bergua J, González-Campos J, Vall-Llovera F, Tormo M, Hernández-Rivas JM, García D, Brunet S, Alonso N, Barba P, Miralles P, Llorente A, Montesinos P, Moreno MJ, Hernández-Rivas JÁ, Bernal T. Ribera JM, et al. Among authors: miralles p. Cancer. 2013 May 1;119(9):1660-8. doi: 10.1002/cncr.27918. Epub 2013 Jan 29. Cancer. 2013. PMID: 23361927 Free article. Clinical Trial.
Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
Ribera JM, Oriol A, Morgades M, González-Barca E, Miralles P, López-Guillermo A, Gardella S, López A, Abella E, García M; PETHEMA, GELTAMO, GELCAB and GESIDA Groups. Ribera JM, et al. Among authors: miralles p. Br J Haematol. 2008 Feb;140(4):411-9. doi: 10.1111/j.1365-2141.2007.06943.x. Epub 2007 Dec 19. Br J Haematol. 2008. PMID: 18162120 Free article. Clinical Trial.
Comparison of CHOP treatment with specific short-intensive chemotherapy in AIDS-related Burkitt's lymphoma or leukemia.
Xicoy B, Ribera JM, Miralles P, La Cruz J, Oriol A, Valencia E, Morgades M, Mahillo B, de la Torre J, Téllez MJ, Brunet S, Esteve J, Hoelzer D; PETHEMA Group; GESIDA Group; GMALL Group. Xicoy B, et al. Among authors: miralles p. Med Clin (Barc). 2011 Mar 26;136(8):323-8. doi: 10.1016/j.medcli.2010.07.025. Epub 2011 Jan 19. Med Clin (Barc). 2011. PMID: 21251683
Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma.
Xicoy B, Ribera JM, Miralles P, Berenguer J, Rubio R, Mahillo B, Valencia ME, Abella E, López-Guillermo A, Sureda A, Morgades M, Navarro JT, Esteban H; GESIDA Group; GELCAB Group. Xicoy B, et al. Among authors: miralles p. Haematologica. 2007 Feb;92(2):191-8. doi: 10.3324/haematol.10479. Haematologica. 2007. PMID: 17296568 Free article.
Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain.
Sancho JM, Morgades M, Alonso N, Deben G, Fernández de Sevilla A, Vázquez L, Nicolás C, García Vela JA, Arranz R, Abella E, Canales MA, Miralles P, Sánchez E, Hermosilla M, Conde E, Rueda A, Ribera JM; investigators of QUIT Study (PETHEMA, GELTAMO and GOTEL Groups). Sancho JM, et al. Among authors: miralles p. Med Clin (Barc). 2008 Oct 11;131(12):441-6. doi: 10.1157/13126952. Med Clin (Barc). 2008. PMID: 18928733
[Diagnosis, prophylaxis and treatment of central nervous system involvement by non-Hodgkin lymphoma in HIV-infected patients].
Miralles P, Berenguer J, Ribera JM; grupo de estudio de la afección del sistema nervioso central en linfomas asociados a la infección por el virus de la inmunodeficiencia. Miralles P, et al. Med Clin (Barc). 2010 Sep 18;135(9):417-22. doi: 10.1016/j.medcli.2009.04.047. Epub 2009 Jul 22. Med Clin (Barc). 2010. PMID: 19628233 Review. Spanish.
Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP.
Ribera JM, Morgades M, González-Barca E, Miralles P, López-Guillermo A, Gardella S, López A, Abella E, García M, Navarro JT, Feliu E. Ribera JM, et al. Among authors: miralles p. Br J Haematol. 2012 Jun;157(5):637-9. doi: 10.1111/j.1365-2141.2012.09046.x. Epub 2012 Feb 7. Br J Haematol. 2012. PMID: 22313456 Free article. Clinical Trial. No abstract available.
Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma.
Baptista MJ, Tapia G, Morgades M, Muncunill J, Muñoz-Marmol AM, Montoto S, Gribben JG, Calaminici M, Martinez A, Gonzalez-Farre B, Dlouhy I, González-Barca E, Terol MJ, Miralles P, Alcoceba M, Vall-Llovera F, Briones J, Abrisqueta P, Abella E, Provencio M, García-Ballesteros C, Moraleda JM, Sancho JM, Ribera JM, Mate JL, Navarro JT. Baptista MJ, et al. Among authors: miralles p. Leuk Lymphoma. 2019 Apr;60(4):1087-1091. doi: 10.1080/10428194.2018.1512711. Epub 2018 Oct 15. Leuk Lymphoma. 2019. PMID: 30322315 No abstract available.
243 results